Targeted Therapy for Gynecological Cancer

GYN eBx® | Electronic Brachytherapy

Explore GYN eBx

With a range of expertly designed applicators for both endometrial and cervical cancer for the female anatomy, simplified, targeted radiation therapy for gynecological cancer treatment in a minimally shielded setting is possible with GYN electronic brachytherapy (eBx). Our gynecological applicators provide a therapeutic dose of radiation therapy for intracavitary treatment of cancer of the uterus, cervix, endometrium and vagina, while minimizing exposure to surrounding healthy tissue such as the bladder and rectum.

By providing select gynecological cancer patients with a concentrated dose of electronic brachytherapy directly to the tumor site, our high dose, low energy technology offers an accelerated course of treatment as compared to traditional radiation therapy. By streamlining the delivery of care, GYN eBx offers increased patient compliance and satisfaction.

Targeted

A miniaturized x-ray source delivers a precise dose of radiation directly to the cancerous site.

Efficient

The Xoft System offers two different angled Colpostat sets to accommodate female anatomy with no radioactive isotopes.

Convenient

While reducing the number of required treatments, GYN eBx is most often performed as an outpatient procedure, delivered in a minimally shielded setting.

Clinically Supported

A growing body of favorable clinical data supports the use of GYN eBx in patients meeting specific selection criteria.1-7

Toxicity results after treatment with electronic brachytherapy in patients with endometrial cancer8

  • 94 patients
  • Treated from September 2015 to September 2017
  • Median follow-up: 11 months
  • Preliminary results show targeted approach reduces toxicity to organs at risk.

lr-192

Xoft 50 kV

The Xoft System is able to precisely target cancer cells and spare surrounding healthy tissue, resulting in a significant reduction in the radiation dose that reaches organs at risk. Our early results with this targeted technology are very promising, and we are pleased to offer this valuable treatment option to appropriately selected patients with endometrial and cervical cancer.

– Agustina Mendez Villamon, MD
Radiation Oncologist
Miguel Servet University Hospital, Zaragoza, Spain

Learn More>

Axxent Controller

The Xoft System is FDA cleared, CE marked, and licensed in a growing number of countries for the treatment of cancer anywhere in the body.

Learn More

Vaginal Applicators

The Axxent® vaginal applicators are a key component of the Xoft® Axxent® Electronic Brachytherapy (eBx®) System®, empowering targeted brachytherapy in the vagina and rectum.

Learn More

Cervical Applicator

The Axxent cervical applicator is a key component of the Xoft® Axxent® Electronic Brachytherapy (eBx®) System®, empowering targeted intracavitary treatment of cancer of the uterus, cervix, endometrium and vagina.

Learn More

©2018 Xoft®, a subsidiary of iCAD, Inc. All rights reserved. Xoft, the Xoft logo, Axxent, Electronic Brachytherapy System and eBx are registered trademarks of iCAD, Inc.  Reproduction of any of the material contained herein in any format or media without the express written permission of iCAD, Inc. is prohibited.

Targeted Therapy for Gynecological Cancer

GYN eBx® | Electronic Brachytherapy

The Xoft System is able to precisely target cancer cells and spare surrounding healthy tissue, resulting in a significant reduction in the radiation dose that reaches organs at risk. Our early results with this targeted technology are very promising, and we are pleased to offer this valuable treatment option to appropriately selected patients with endometrial and cervical cancer.

– Agustina Mendez Villamon, MD
Radiation Oncologist
Miguel Servet University Hospital, Zaragoza, Spain